Clinical Evidence on GLP-1 Receptor Agonist and Cancer Risk
GLP-1 receptor agonist cancer risk is an emerging area of clinical research. Recent studies suggest potential benefits in reducing cancer recurrence and improving survival. This evidence is important for prescribers managing obese patients with diabetes…
GLP-1 Receptor Agonists and Breast Cancer Outcomes
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational StudyBreast CancerGLP-1 Receptor AgonistOncologyAdults…
Clinical Evidence on GLP-1 Receptor Agonist and Breast Cancer Outcomes
GLP-1 receptor agonist breast cancer outcomes show promising clinical evidence for improved survival in patients with obesity. These drugs impact metabolic health and inflammation, influencing cancer biology. Understanding these outcomes aids prescribers…
Topical Cannabis for AIMSS: Clinical Trial Evidence
Clinical Takeaway Topical cannabis balms were tolerable and feasible for women with aromatase inhibitor-related joint pain and stiffness, which affects about two-thirds of women taking these breast cancer medications. This approach could help improve…
Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Topical cannabinoids for AIMSS offer a promising approach to managing joint pain and stiffness caused by aromatase inhibitor therapy. Clinical trials show these balms are generally well-tolerated and feasible for use. This evidence-based care option may…
Topical Cannabis for AIMSS: Medical Cannabis Evidence
This study evaluates topical cannabinoid application feasibility in postmenopausal breast cancer patients with AIMSS. The trial found topical cannabis balms to be well tolerated. These results support further research on topical cannabinoid application…
Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical Translation.
This review highlights cannabinoid anti-tumor effects breast cancer research and its potential to enhance conventional therapies. It emphasizes the gap between preclinical findings and clinical translation. Understanding these effects is crucial for…
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Topical cannabis balms AIMSS treatment was evaluated in a randomized trial among breast cancer survivors experiencing musculoskeletal pain. The study assessed feasibility, tolerability, and preliminary efficacy of CBD and THC balms. Results provide early…